Nanopore Sequencing Market Size, Scope, Forecast Report 2026 to 2035
Segmentation of Nanopore Sequencing Market-
Nanopore Sequencing Market- By Product
- Instruments
- Consumables
Nanopore Sequencing Market- By Type of Nucleotide Sequenced
- DNA
- RNA
Nanopore Sequencing Market- By Type of Nanopore
- Solid State
- Biological
- Hybrid
Nanopore Sequencing Market- By Application
- Clinical Research
- Human Genetics
- Animal Research
- Others
Nanopore Sequencing Market- By End-User
- Clinical Laboratories
- Biotechnological Companies
- Academic & Research Institutes
- Others
Nanopore Sequencing Market- By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanopore Sequencing Market Snapshot
Chapter 4. Global Nanopore Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026 2035
4.8. Global Nanopore Sequencing Market Penetration & Growth Prospect Mapping (US$ Mn), 2022 to 2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025 to 2035)
4.10. Use/impact of AI on Radiopharma Industry Trends
Chapter 5. Nanopore Sequencing Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Product:
5.2.1. Instruments
5.2.2. Consumables
Chapter 6. Nanopore Sequencing Market Segmentation 2: By Type of Nanopore, Estimates & Trend Analysis
6.1. Market Share by Type of Nanopore, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Nanopore:
6.2.1. Solid State
6.2.2. Biological
6.2.3. Hybrid
Chapter 7. Nanopore Sequencing Market Segmentation 3: By Type of Nucleotide Sequenced, Estimates & Trend Analysis
7.1. Market Share by Type of Nucleotide Sequenced 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Nucleotide Sequenced:
7.2.1. DNA
7.2.2. RNA
Chapter 8. Nanopore Sequencing Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share by Application, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Application:
8.2.1. Human Genetics
8.2.2. Clinical Research
8.2.3. Animal Research
8.2.4. Others
Chapter 9. Nanopore Sequencing Market Segmentation 5: By End-user, Estimates & Trend Analysis
9.1. Market Share by End-user, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following End-user:
9.2.1. Biotechnological Companies
9.2.2. Clinical Laboratories
9.2.3. Academic & Research Institutes
9.2.4. Others
Chapter 10. Nanopore Sequencing Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Nanopore Sequencing Market, Regional Snapshot 2025 & 2035
10.2. North America
10.2.1. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022 - 2035
10.2.3. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2022 - 2035
10.2.4. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2022 - 2035
10.2.5. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022 - 2035
10.2.6. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022 - 2035
10.3. Europe
10.3.1. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.3.1.1. Denmark
10.3.1.2. Finland
10.3.1.3. Austria
10.3.1.4. France
10.3.1.5. Germany
10.3.1.6. Israel
10.3.1.7. Italy
10.3.1.8. Netherlands
10.3.1.9. Norway
10.3.1.10. Poland
10.3.2. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022 - 2035
10.3.3. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2022 - 2035
10.3.4. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2022 - 2035
10.3.5. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022 - 2035
10.3.6. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022 - 2035
10.4. Asia Pacific
10.4.1. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.4.1.1. Australia
10.4.1.2. China
10.4.1.3. India
10.4.1.4. Indonesia
10.4.1.5. Japan
10.4.1.6. Malaysia
10.4.1.7. Philippines
10.4.1.8. Singapore
10.4.1.9. South Korea
10.4.1.10. Taiwan
10.4.1.11. Thailand
10.4.1.12. Rest of APAC
10.4.2. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022 - 2035
10.4.3. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2022 - 2035
10.4.4. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts By Type of Nucleotide Sequenced 2022 - 2035
10.4.5. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022 - 2035
10.4.6. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022 - 2035
10.5. Latin America
10.5.1. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.5.1.1. Argentina
10.5.1.2. Brazil
10.5.1.3. Mexico
10.5.1.4. Rest of LATAM
10.5.2. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022 - 2035
10.5.3. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2022 - 2035
10.5.4. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2022 - 2035
10.5.5. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022 - 2035
10.5.6. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022 - 2035
10.6. Middle East & Africa
10.6.1. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035
10.6.1.1. Egypt
10.6.1.2. Israel
10.6.1.3. Nigeria
10.6.1.4. Saudi Arabia
10.6.1.5. Qatar
10.6.1.6. United Arab Emirates
10.6.1.7. Rest of MEA
10.6.2. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022 - 2035
10.6.3. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2022 - 2035
10.6.4. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2022 - 2035
10.6.5. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022 - 2035
10.6.6. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022 - 2035
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Pacific Biosciences
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Modeance
11.2.1.5. Geographical Presence
11.2.1.6. Recent Developments with Business Strategy
11.2.2. Oxford Nanopore Technologies Limited
11.2.3. QIAGEN
11.2.4. Eurofins Scientific
11.2.5. Agilent Technologies, Inc.
11.2.6. F. Hoffmann-La Roche Ltd.
11.2.7. Bio-Rad Laboratories, Inc.
11.2.8. Danaher Corporation, PerkinElmer Inc.
11.2.9. Thermo Fisher Scientific
11.2.10. Myriad Genetics, Inc.
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Nanopore Sequencing Market Size was valued at USD 380.95 Mn in 2025 and is predicted to reach USD 1,169.93 Mn by 2035.
Nanopore Sequencing Market is expected to grow at a 12.0% CAGR during the forecast period for 2026-2035.
Bio-Rad Laboratories, Inc., Danaher Corporation, Pacific Biosciences, Oxford Nanopore Technologies Limited, QIAGEN, F. Hoffmann-La Roche Ltd., PerkinE
nanopore sequencing market is segmented based on product, type of nucleotide sequenced, type of nanopore, application, and end-user, solid state, biological, and hybrid.
North America region is leading the Nanopore Sequencing Market.